EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 234 filers reported holding EXELIXIS INC in Q4 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $6,010,548 | -53.0% | 253,289 | -52.5% | 0.03% | -59.0% |
Q4 2023 | $12,800,560 | -42.6% | 533,579 | -47.7% | 0.08% | -49.7% |
Q3 2023 | $22,313,198 | +149.8% | 1,021,199 | +118.4% | 0.16% | +179.7% |
Q2 2023 | $8,933,963 | -15.3% | 467,502 | -14.0% | 0.06% | -7.8% |
Q1 2023 | $10,548,132 | +1081.7% | 543,438 | +876.5% | 0.06% | +1180.0% |
Q4 2022 | $892,658 | -78.8% | 55,652 | -79.3% | 0.01% | -79.2% |
Q3 2022 | $4,213,000 | -45.4% | 268,665 | -27.5% | 0.02% | -48.9% |
Q2 2022 | $7,721,000 | +3.6% | 370,822 | +12.8% | 0.05% | -25.4% |
Q1 2022 | $7,454,000 | +177.0% | 328,793 | +123.4% | 0.06% | +142.3% |
Q4 2021 | $2,691,000 | -43.2% | 147,191 | -34.3% | 0.03% | -56.7% |
Q3 2021 | $4,736,000 | +24.4% | 224,035 | +7.2% | 0.06% | +39.5% |
Q2 2021 | $3,808,000 | -2.1% | 208,987 | +21.4% | 0.04% | -14.0% |
Q1 2021 | $3,889,000 | +115.6% | 172,172 | +91.6% | 0.05% | +100.0% |
Q4 2020 | $1,804,000 | -63.4% | 89,876 | -55.4% | 0.02% | -65.8% |
Q3 2020 | $4,928,000 | -46.7% | 201,552 | -48.3% | 0.07% | -54.4% |
Q2 2020 | $9,252,000 | +149.9% | 389,743 | +81.3% | 0.16% | +60.0% |
Q1 2020 | $3,703,000 | +1324.2% | 215,023 | +1356.7% | 0.10% | +1900.0% |
Q4 2019 | $260,000 | +348.3% | 14,761 | +347.3% | 0.01% | +400.0% |
Q3 2019 | $58,000 | -91.5% | 3,300 | -89.6% | 0.00% | -91.7% |
Q2 2019 | $679,000 | -73.6% | 31,788 | -70.6% | 0.01% | -85.5% |
Q1 2019 | $2,575,000 | +49.6% | 108,181 | +23.7% | 0.08% | +2.5% |
Q4 2018 | $1,721,000 | +485.4% | 87,477 | +427.5% | 0.08% | +406.2% |
Q3 2018 | $294,000 | -23.0% | 16,582 | -6.6% | 0.02% | -15.8% |
Q2 2018 | $382,000 | -35.8% | 17,757 | -33.9% | 0.02% | -45.7% |
Q1 2018 | $595,000 | -60.0% | 26,861 | -45.1% | 0.04% | -55.7% |
Q4 2017 | $1,488,000 | +6.1% | 48,954 | -15.5% | 0.08% | 0.0% |
Q3 2017 | $1,403,000 | +51.3% | 57,914 | +53.8% | 0.08% | +33.9% |
Q2 2017 | $927,000 | +82.5% | 37,648 | +60.7% | 0.06% | +63.9% |
Q1 2017 | $508,000 | -67.4% | 23,424 | -77.6% | 0.04% | -71.0% |
Q4 2016 | $1,557,000 | +115.4% | 104,458 | +84.7% | 0.12% | +169.6% |
Q3 2016 | $723,000 | +256.2% | 56,564 | +117.9% | 0.05% | +283.3% |
Q2 2016 | $203,000 | +170.7% | 25,955 | +39.0% | 0.01% | +200.0% |
Q1 2016 | $75,000 | -88.6% | 18,670 | -84.0% | 0.00% | -89.7% |
Q4 2015 | $658,000 | -39.3% | 116,611 | -39.6% | 0.04% | -29.1% |
Q3 2015 | $1,084,000 | +2206.4% | 193,179 | +1433.2% | 0.06% | +2650.0% |
Q2 2015 | $47,000 | +2.2% | 12,600 | -29.9% | 0.00% | 0.0% |
Q1 2015 | $46,000 | +155.6% | 17,980 | +42.7% | 0.00% | +100.0% |
Q4 2014 | $18,000 | -5.3% | 12,600 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $19,000 | -67.8% | 12,600 | -27.2% | 0.00% | -75.0% |
Q2 2014 | $59,000 | – | 17,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |